查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
无血清市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按介质类型、终端用户、公司和地区分类
市场调查报告书
商品编码
1289658

无血清市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按介质类型、终端用户、公司和地区分类

Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在2023-2027年的预测期内，全球无血清市场预计将出现令人瞩目的增长。主要因素包括传染病和慢性病的流行率上升，癌症治疗对细胞疗法的需求，以及研发活动的增加，这些都推动了市场的增长。无血清培养基是用于在没有血清的情况下生长特定的细胞类型或执行特定的应用的培养基。无血清培养基（SFM）的使用标志着一种重要的工具，它使细胞培养能够在一套确定的条件下进行，并尽可能不存在混杂的变量。支持市场增长的其他因素是，对各种重组蛋白和培养类型的需求不断增加，罕见疾病的患者登记不断扩大，下游处理更加容易，开发新型治疗药物的研究和开发不断增加，生物制药行业和生物制药生产的扩大，采用先进技术，以及研究和开发活动的增加。此外，不断增加的战略增长，如合并、合作和收购，正在加强市场的增长。例如，在2019年，Sartorius宣布收购细胞培养基专家生物公司的大部分股份。

传染病和慢性病的发病率不断上升

心血管疾病、糖尿病、性病、呼吸道感染和院内感染等传染病和慢性病的发病率上升，正在推动全球市场的增长。由于生活方式的改变、社会行为和不健康的饮食选择，人们正在遭受这些疾病的困扰，这推动了市场的增长。根据世界卫生组织（WHO）的数据，传染病每年造成约1700万人死亡。老年人群是这些疾病的高发人群，如骨科疾病、流感、心血管疾病、结核病、神经系统疾病和鼻腔内（医院获得的）感染。根据国家肾脏基金会的数据，在全球范围内，65至74岁的人中有四分之一的女性和五分之一的男性患有慢性肾脏病。无血清培养基被用于许多类型的悬浮和粘附培养，以生产免疫细胞，如细胞毒性淋巴细胞（CTL）、IL-2、IL-4和单核细胞，这些细胞被用于生产各种疫苗。

随着无血清培养基的采用，生物制药生产不断增加

由于无血清培养基的特性，如较低的传染病风险、较少的污染物和较低的干扰成分风险，生物制药生产的增加和无血清培养基的采用，正在促进市场的增长。由于各种疾病的发病率上升，治疗这些疾病的需求也在激增。这要归功于生物制药的高效力，这使它们成为治疗的选择，从而增加了生物制药的生产。因此，生物制药行业的扩张和生产的增加正在增强市场的增长。例如，在2019年，药物评价和研究中心批准了48种新药，其中28%是生物制剂。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球无血清媒体市场的影响

第五章：客户的声音

第六章：全球无血清培养基市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按介质类型（普通无血清，无异种，化学定义，无蛋白，其他）
    • 按终端用户（生物技术和制药公司、学术和研究机构、合同研究机构、其他）分类
    • 按公司分类（2021年）
    • 按地区分类
  • 市场地图

第七章：北美无血清培养基市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按介质类型
    • 按终端用户分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第8章：欧洲无血清培养基市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按介质类型
    • 按终端用户分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区无血清培养基市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按介质类型
    • 按终端用户分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美无血清培养基市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按介质类型
    • 按终端用户分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲无血清培养基市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按介质类型
    • 按终端用户分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 无血清培养基
    • 沙特阿拉伯无血清媒体
    • 阿联酋 无血清媒体

第12章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势和发展

第十四章：竞争格局（包括SWOT分析）

  • 康宁公司
  • 龙沙集团股份有限公司
  • Merck KgaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • FUJIFILM控股有限公司
  • PromoCell GmbH
  • 雅典娜环境科学公司
  • STEMCELL Technologies Inc.
  • 丹纳赫公司
  • 研发系统公司
  • 中国生物制品公司
  • 海明威实验室有限公司
  • PAN-生物技术有限公司
  • MP Biomedicals, LLC

第十五章：战略建议

简介目录
Product Code: 13046

The global serum-free market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the rising prevalence of infectious and chronic diseases, demand for cell therapies for cancer treatment, and an increase in R&D activities that are impelling the growth of the market. Serum-free media are media intended to grow a specific cell type or execute a specific application in the absence of serum. The use of serum-free media (SFM) signifies an essential tool that enables cell culture to be performed with a defined set of conditions as free as possible of confounding variables. The other factors supporting the market's growth are, increasing demand for various recombinant proteins and types of culture, expanding patient registry for rare diseases, easier downstream processing, growing research & development for the development of novel therapeutic drugs, expansion of biopharmaceutical industries and biopharma production, adoption of advanced technology, and rise in research and development activities. Also, the increasing strategic growth, such as mergers, collaborations, and acquisitions, is strengthening the growth of the market. For instance, in 2019, Sartorius declared the acquisition of a majority stake in cell culture media specialist biological companies.

Rising Prevalence of Infectious and Chronic Diseases

The rising incidences of infectious and chronic diseases such as cardiovascular diseases, diabetes, STD, respiratory infections, and nosocomial (hospital-acquired) infections are bolstering the growth of the market globally. Owing to lifestyle changes, social behavior, and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. According to the World Health Organization (WHO), infectious diseases kill around 17 million people a year. Geriatric populations are highly prone to these diseases, such as orthopedic diseases, influenza, cardiovascular diseases, tuberculosis, neurological disorders, and nosocomial (hospital-acquired) infections. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe. Serum-free media is used in numerous types of suspension and adherent cultures to produce immunological cells such as cytotoxic lymphocytes (CTLs), IL-2, IL-4, and monocytes, which are utilized in the production of a variety of vaccines.

Increasing Biopharmaceutical Production with the Adoption of Serum-Free Media

The increase in biopharmaceutical production with the rise in adoption of serum-free media, due to its properties such as lower risks of infectious agents, fewer contaminants, and lower risk of interfering components, is facilitating the growth of the market. Owing to the rising incidences of various diseases, the demand to treat these diseases is also surging. This is attributed to the high potency of biopharmaceuticals, which enables them to be the choice of treatment, thus increasing biopharmaceutical production. Thus, the expansion of biopharmaceutical industries and the rise in production are augmenting the growth of the market. For Instance, in 2019, the Center for Drug Evaluation and Research approved 48 new drugs in which, 28% of which were biologics.

Market Segmentation

The global serum-free market is segmented into media type, end user, and company. Based on the media type, the market is segmented into common serum-free, xeno-free, chemically defined, protein-free, and others. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research organizations, contract research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of research and development and clinical trial programs in the country.

Market Players

Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC are some of the leading companies operating in the market.

Report Scope

In this report, global serum-free market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Serum Free Market, By Media Type:

  • Common Serum Free
  • Xeno-Free
  • Chemically Defined
  • Protein-Free
  • Others

Serum Free Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Organizations
  • Contract Research Organizations
  • Others

Serum Free Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Serum Free Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Serum Free Media Market

5. Voice of Customer

6. Global Serum Free Media Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others)
    • 6.2.2. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Serum Free Media Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Media Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Serum Free Media Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Media Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Canada Serum Free Media Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Media Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Mexico Serum Free Media Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Media Type
        • 7.3.3.2.2. By End User

8. Europe Serum Free Media Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Media Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Serum Free Media Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Media Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Serum Free Media Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Media Type
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Serum Free Media Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Media Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Serum Free Media Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Media Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Serum Free Media Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Media Type
        • 8.3.5.2.2. By End User

9. Asia-Pacific Serum Free Media Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Media Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Serum Free Media Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Media Type
        • 9.3.1.2.2. By End User
    • 9.3.2. India Serum Free Media Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Media Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Japan Serum Free Media Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Media Type
        • 9.3.3.2.2. By End User
    • 9.3.4. South Korea Serum Free Media Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Media Type
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Serum Free Media Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Media Type
        • 9.3.5.2.2. By End User

10. South America Serum Free Media Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Media Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Serum Free Media Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Media Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Serum Free Media Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Media Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Serum Free Media Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Media Type
        • 10.3.3.2.2. By End User

11. Middle East and Africa Serum Free Media Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Media Type
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Serum Free Media Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Media Type
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Serum Free Media Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Media Type
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Serum Free Media Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Media Type
        • 11.3.3.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive SWOT Analysis)

  • 14.1. Corning Incorporated
  • 14.2. Lonza Group AG
  • 14.3. Merck KgaA
  • 14.4. Sartorius AG
  • 14.5. Thermo Fisher Scientific Inc.
  • 14.6. FUJIFILM Holdings Corporation
  • 14.7. PromoCell GmbH
  • 14.8. Athena Environmental Sciences, Inc.
  • 14.9. STEMCELL Technologies Inc.
  • 14.10. Danaher Corporation
  • 14.11. R&D Systems, Inc.
  • 14.12. Sino Biological, Inc.
  • 14.13. HiMedia Laboratories, LLC
  • 14.14. PAN-Biotech GmbH
  • 14.15. MP Biomedicals, LLC

15. Strategic Recommendations